Press Releases

MADISON, Wis., June 8, 2021 – Cellular Logistics has joined Forward BIOLABS, a non-profit, co-working life science lab for an early-stage biotech. Forward BIOLABS life science laboratories are fully equipped, maintained, supported, and come with introductions, training, and networking that help startups grow. It was founded...

MADISON, Wis., March 09, 2021 – Cellular Logistics has been awarded a $321,000 SBIR grant from the National Institutes of Health to optimize an induced pluripotent stem cell-derived cardiac fibroblast (iPSC-CF) technology to assemble Tandem™ HF biomaterial to facilitate heart failure treatment.    The aim of this grant is to develop a second manufacturing pipeline of cardiac fibroblasts to manufacture Cellular Logistics’ novel Tandem™ HF biomaterial. iPSC-CF has the potential to offer a new predictable, renewable, and...

MADISON, Wis., June 25, 2019 – Cellular Logistics today announced the publication of an article in Nature Communications that details of a cell-production advancement with significant positive implications for the commercialization of the company’s Tandem™ technology. The article, titled Functional cardiac fibroblasts derived from human...

MADISON, Wis., May 7, 2019 – Cellular Logistics Inc., the UW-Madison spinoff focused on delivering new ways to treat heart failure and restore heart function, today announced the appointment of Alex Vodenlich as president and chief executive. Mr. Vodenlich also will join the company’s board...

Cellular Logistics Founder, Dr. Amish Raval, has been awarded $107,000 from the State Economic Engagement and Development (SEED) Research Program for a proposal entitled, "Bioengineered Injectable Matrix to Improve Stem Cell Retention for Heart Repair." The press release can be viewed here....